B. Chamorro

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab

E. Díez-Tejedor, C. Oreja-Guevara, Jaime Ramos-Cejudo, 2012, BMC Neurology.

Treatment with Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism

E. Díez-Tejedor, C. Oreja-Guevara, Jaime Ramos-Cejudo, 2011, Journal of Clinical Immunology.

Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon

Mireya Fernández-Fournier, P. Martínez-Sánchez, A. Tallón‐Barranco, 2015, BMC Neurology.

Human intoxication with paralytic shellfish toxins: clinical parameters and toxin analysis in plasma and urine.

N. Lagos, V. Iglesias, M. Lagos, 2005, Biological research.